IFNB1 and central nervous system cancer: To evaluate the safety, feasibility, and clinical effectiveness of combination therapy with IFN-β and TMZ, a phase I clinical study, the Integrated Japanese Multicenter Clinical Trial: a Phase I Study of Interferon-β and TMZ for Glioma in Combination with RT (INTEGRA study), was conducted.